CAPTRUST Financial Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9K | Buy |
+44,447
| New | +$31.9K | ﹤0.01% | 2459 |
|
|
2025
Q1 | – | Sell |
-26,894
| Closed | -$119K | – | 2407 |
|
|
2024
Q4 | $119K | Buy |
26,894
+153
| +0.6% | +$678 | ﹤0.01% | 2192 |
|
|
2024
Q3 | $110K | Sell |
26,741
-877
| -3% | -$3.61K | ﹤0.01% | 2197 |
|
|
2024
Q2 | $180K | Buy |
27,618
+868
| +3% | +$5.66K | ﹤0.01% | 2064 |
|
|
2024
Q1 | $233K | Sell |
26,750
-3,013
| -10% | -$26.2K | ﹤0.01% | 1919 |
|
|
2023
Q4 | $340K | Buy |
+29,763
| New | +$340K | ﹤0.01% | 2019 |
|
|
2022
Q3 | – | Sell |
-6,690
| Closed | -$77K | – | 3050 |
|
|
2022
Q2 | $77K | Buy |
6,690
+5,455
| +442% | +$62.8K | ﹤0.01% | 2414 |
|
|
2022
Q1 | $16K | Buy |
1,235
+142
| +13% | +$1.84K | ﹤0.01% | 3530 |
|
|
2021
Q4 | $13K | Buy |
1,093
+394
| +56% | +$4.69K | ﹤0.01% | 3563 |
|
|
2021
Q3 | $9K | Sell |
699
-53
| -7% | -$682 | ﹤0.01% | 3669 |
|
|
2021
Q2 | $10K | Sell |
752
-2,970
| -80% | -$39.5K | ﹤0.01% | 3542 |
|
|
2021
Q1 | $42K | Buy |
3,722
+3,670
| +7,058% | +$41.4K | ﹤0.01% | 2543 |
|
|
2020
Q4 | $1K | Buy |
+52
| New | +$1K | ﹤0.01% | 3263 |
|